AM

Azeer Muhammed Kunju

Active Director Additional Director DIN 11335284
DIN 11335284 First appointment Oct 2025 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Oct 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Azeer Muhammed Kunju

Data last updated:

Azeer Muhammed Kunju is an Additional Director at Ayurdeyam Ayurveda Hospital And Research Center Private Limited (since 2025). The company operates in Healthcare.

DIN 11335284
Primary Designation Additional Director
Industry Healthcare
First Appointment 17 Oct 2025

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Additional Director17 Oct 2025Active

Board colleagues of Azeer Muhammed Kunju

Directorship timeline

Open interactive timeline →
Ayurdeyam Ayurveda Hospital And Research Center Private Limited
Premium access

Shareholding and investment profile for Azeer Muhammed Kunju

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Azeer Muhammed Kunju

Azeer Muhammed Kunju currently holds 1 directorship: Ayurdeyam Ayurveda Hospital And Research Center Private Limited (Additional Director, since 17 Oct 2025).

Azeer Muhammed Kunju was first appointed on 17 Oct 2025 as Additional Director at Ayurdeyam Ayurveda Hospital And Research Center Private Limited.

The current boards of Azeer Muhammed Kunju's companies include Chandran Thodi Muhammed Sainul Abid (Ayurdeyam Ayurveda Hospital And Research Center Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available